The cell therapy market is swiftly progressing, propelled by significant breakthroughs in medical research and a growing embrace of novel treatments in various therapeutic fields. The global industry is estimated to be valued at US$ 4.8 billion in...
Conduit Pharmaceuticals Inc. announced that it has established a strategic services partnership with the formulation development CDMO Agility Life Sciences (“Agility”) to create new solid oral-dosage form products for its autoimmune pipeline...
Hoth Therapeutics, Inc., a biopharmaceutical firm centered on patients, is pleased to announce progress in its intellectual property holdings by acquiring and expanding patent applications related to its cutting-edge therapeutic pipeline...
BioNxt Solutions Inc, a bioscience firm focused on cutting-edge drug delivery systems, is thrilled to share a significant achievement in its research and development progress. The firm is moving its innovative R&D tasks to the Gen-Plus Contract...
Glenmark Pharmaceuticals announced that its US division has introduced the anticoagulant Phytonadione injectable emulsion. Glenmark Pharmaceuticals Inc., USA has introduced a 10 mg/mL injectable emulsion of Phytonadione in single-dose ampules...
InnoCare Pharma and KeyMed Biosciences announced that they, along with their joint venture, have collectively signed an exclusive licensing agreement with Prolium Bioscience (Prolium) for the advancement and marketing of ICP-B02 (CM355)...
Indian pharmaceutical experts anticipate positive trade conditions with Donald Trump assuming the presidency of the US. The United States continues to be an important market for Indian pharmaceutical firms, representing roughly 30% of India's...
Caris Life Sciences (Caris), a prominent next-generation AI TechBio firm and a leader in precision medicine, revealed a strategic and multifaceted partnership with Ontada, a company focused on oncology real-world evidence, clinical education, and...
Innovent Biologics, Inc. (Innovent), a premier biopharmaceutical firm that develops, produces, and markets high-quality medications for treating oncology, cardiovascular and metabolic disorders, autoimmune diseases, ophthalmology, and other...
Japanese pharmaceutical firm Takeda opened its inaugural Innovation Capability Centre (ICC) in Bengaluru, signifying its first venture in Asia. The ICC plans to hire 750 professionals, such as software engineers, data scientists, and cybersecurity...
, CDSCO.jpg)
